北京柏雅联合药物研究所有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
21
NMPA:21
Drug Approvals
Procaterol Hydrochloride Inhalation Solution
- Product Name
- 盐酸丙卡特罗吸入溶液
- Approval Number
- 国药准字H20254534
- Approval Date
- Jun 10, 2025
NMPA
Magnesium Sulfate Injection
- Product Name
- 硫酸镁注射液
- Approval Number
- 国药准字H20253604
- Approval Date
- Mar 11, 2025
NMPA
Sodium Chloride Physiological Solution
- Product Name
- 生理氯化钠溶液
- Approval Number
- 国药准字H20253140
- Approval Date
- Jan 14, 2025
NMPA
Pravastatin Sodium Tablets
- Product Name
- 普伐他汀钠片
- Approval Number
- 国药准字H20249609
- Approval Date
- Dec 1, 2024
NMPA
Cetirizine Hydrochloride Drops
- Product Name
- 盐酸西替利嗪滴剂
- Approval Number
- 国药准字H20234199
- Approval Date
- Apr 18, 2024
NMPA
Potassium Chloride Granules
- Product Name
- 氯化钾颗粒
- Approval Number
- 国药准字H20243491
- Approval Date
- Apr 11, 2024
NMPA
Compound Vitamin (3) Injection
- Product Name
- 复方维生素(3)注射液
- Approval Number
- 国药准字H20140034
- Approval Date
- Feb 29, 2024
NMPA
Compound Glycyrrhizin Capsules
- Product Name
- 复方甘草酸苷胶囊
- Approval Number
- 国药准字H20080677
- Approval Date
- May 22, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found